DIS	A
CON	Breakthrough
CON	Opportunity
REL	for
ORG	Global
ORG	Health
CON	NEW YORK
NIL	–
AND	Every
CON	year
EQU	,
CON	millions
AND	of
CON	people
EXS	die
REL	from
IST	preventable
AND	and
IST	treatable
CON	diseases
NIL	,
AND	especially
REL	in
IST	poor
CON	countries
NIL	.
REL	In
QUV	many
CON	cases
NIL	,
REL	lifesaving
CON	medicines
POS	can
EXS	be
IST	cheaply
EXS	mass-produced
NIL	,
BUT	but
NOW	are
EXS	sold
REL	at
CON	prices
SUB	that
EXS	block
CON	access
REL	to
DST	those
AND	who
ENS	need
PRO	them
NIL	.
AND	And
QUC	many
EXS	die
IST	simply
SUB	because
UNK	there
NOW	are
NOT	no
CON	cures
DIS	or
CON	vaccines
NIL	,
SUB	because
IST	so
CON	little
AND	of
DEF	the
CON	world
NOW	’s
IST	valuable
CON	research
CON	talent
AND	and
IST	limited
CON	resources
NOW	is
EXS	devoted
SUB	to
EXS	addressing
DEF	the
CON	diseases
AND	of
DEF	the
CON	poor
NIL	.
PRX	This
CON	state
AND	of
CON	affairs
NOW	represents
DIS	a
CON	failure
AND	of
CON	economics
AND	and
CON	law
AND	that
IST	urgently
ENS	needs
SUB	to
EXS	be
EXS	corrected
NIL	.
DEF	The
IST	good
CON	news
NOW	is
SUB	that
UNK	there
NOW	are
NOW	now
CON	opportunities
REL	for
CON	change
EQU	,
INT	most
IST	promisingly
AND	through
DIS	an
IST	international
CON	effort
EPS	headed
REL	by
DEF	the
ORG	World Health
ORG	Organization
SUB	that
FUT	would
EXS	begin
SUB	to
EXS	fix
DEF	the
IST	broken
CON	intellectual-property
CON	regime
AND	that
NOW	is
EXS	holding
IST	back
DEF	the
CON	development
AND	and
CON	availability
AND	of
IST	cheap
CON	drugs
NIL	.
QUC	Two
IST	main
CON	problems
EXS	limit
DEF	the
CON	availability
AND	of
CON	medicines
NOW	today
NIL	.
QUC	One
NOW	is
SUB	that
PRO	they
NOW	are
INT	very
EXS	costly
NIL	;
DIS	or
NIL	,
IST	more
IST	accurately
NIL	,
DEF	the
CON	price
EXS	charged
REL	for
PRO	them
NOW	is
INT	very
EXS	high
NIL	,
SUB	though
DEF	the
CON	cost
AND	of
EXS	producing
PRO	them
NOW	is
BUT	but
DIS	a
CON	fraction
AND	of
DST	that
CON	amount
NIL	.
PER	Second
NIL	,
CON	drug
CON	development
NOW	is
EXS	geared
AND	toward
EXS	maximizing
CON	profit
NIL	,
NOT	not
IST	social
CON	benefit
NIL	,
AND	which
CON	skews
CON	efforts
EXS	directed
REL	at
DEF	the
CON	creation
AND	of
CON	medicines
AND	that
NOW	are
EXS	essential
REL	to
IST	human
CON	welfare
NIL	.
AND	Because
DEF	the
CON	poor
NOW	have
INT	so
IST	little
CON	money
SUB	to
EXS	spend
NIL	,
CON	drug
CON	companies
NIL	,
REL	under
IST	current
CON	arrangements
NIL	,
NOW	have
IST	little
CON	incentive
SUB	to
EXS	do
CON	research
REL	on
DEF	the
CON	diseases
AND	that
REL	afflict
PRO	them
NIL	.
PRO	It
NOW	does
NOT	n’t
NEC	have
SUB	to
EXS	be
PRX	this
CON	way
NIL	.
ORG	Drug
CON	companies
NOW	argue
SUB	that
IST	high
CON	prices
NOW	are
IST	necessary
SUB	to
EXS	fund
CON	research
AND	and
CON	development
NIL	.
AND	But
NIL	,
REL	in
DEF	the
CON	United States
NIL	,
PRO	it
NOW	is
IST	actually
DEF	the
CON	government
AND	that
CON	finances
TOP	most
NIL	health-related
CON	research
AND	and
CON	development
NIL	–
IST	directly
NIL	,
AND	through
IST	public
CON	support
NIL	(
ORG	National Institutes
AND	of
ORG	Health
EQU	,
ORG	National Science
ORG	Foundation
NIL	)
NIL	,
AND	and
IST	indirectly
NIL	,
AND	through
IST	public
CON	purchases
AND	of
CON	medicine
NIL	,
AND	both
REL	in
DEF	the
ORG	Medicare
AND	and
ORG	Medicaid
CON	programs
NIL	.
AND	Even
DEF	the
CON	part
AND	that
NOW	is
NOT	not
IST	government-financed
NOW	is
NOT	not
DIS	a
IST	conventional
CON	market
COO	;
IST	most
CON	individuals
AND	’
CON	purchases
AND	of
CON	prescription
CON	medicines
NOW	are
EXS	covered
REL	by
CON	insurance
NIL	.
ORG	Government
CON	finances
REL	health-care
CON	research
AND	because
IST	improved
CON	medicines
NOW	are
DIS	a
IST	public
IST	good
NIL	.
DEF	The
EXG	resulting
CON	knowledge
CON	benefits
AND	everyone
REL	by
EXS	stopping
CON	epidemics
COO	and
EXS	limiting
DEF	the
IST	economic
AND	and
IST	human
CON	toll
AND	of
IST	widespread
CON	illness
NIL	.
